These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9288250

  • 21. Tenotomy of the tensor tympani and stapedius tendons in Ménière's disease.
    De Valck CF, Van Rompaey V, Wuyts EL, Van de Heyning PH.
    B-ENT; 2009; 5(1):1-6. PubMed ID: 19455992
    [Abstract] [Full Text] [Related]

  • 22. Brain and inner-ear fluid homeostasis, cochleovestibular-type tinnitus, and secondary endolymphatic hydrops.
    Shulman A, Goldstein B.
    Int Tinnitus J; 2006; 12(1):75-81. PubMed ID: 17147045
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Quality of life instruments in Ménière's disease.
    Green JD, Verrall A, Gates GA.
    Laryngoscope; 2007 Sep; 117(9):1622-8. PubMed ID: 17667131
    [Abstract] [Full Text] [Related]

  • 25. Psychological characteristics of patients with Ménière's disease compared with patients with vertigo, tinnitus, or hearing loss.
    Savastano M, Marioni G, Aita M.
    Ear Nose Throat J; 2007 Mar; 86(3):148-56. PubMed ID: 17427776
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK, Sismanis A, Spencer RF, Wise CM.
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [Abstract] [Full Text] [Related]

  • 29. Drop attacks with Menière's syndrome.
    Baloh RW, Jacobson K, Winder T.
    Ann Neurol; 1990 Sep; 28(3):384-7. PubMed ID: 2241120
    [Abstract] [Full Text] [Related]

  • 30. Prediction of vertigo recurrences in Meniere's disease by the head-shaking test.
    Kamei T, Iizuka T.
    Int Tinnitus J; 1999 Sep; 5(1):47-9. PubMed ID: 10753419
    [Abstract] [Full Text] [Related]

  • 31. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 32. Predominance of left ear in Meniére's disease, sudden deafness, inner ear damage, tinnitus and abnormally patent eustachian tube.
    Heermann J.
    Ear Nose Throat J; 1993 Mar; 72(3):205-8. PubMed ID: 8482264
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
    Longridge NS, Mallinson AI.
    J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
    [Abstract] [Full Text] [Related]

  • 37. Staging Meniere's disease: description of a vertigo-disability profile.
    Stahle J, Arenberg IK, Goldman G.
    Am J Otol; 1981 Apr; 2(4):357-64. PubMed ID: 7258328
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical applications and importance of selected, modern results of hearing research].
    Ernst A, Zenner HP.
    Wien Med Wochenschr; 1992 Apr; 142(20-21):450-4. PubMed ID: 1488842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.